Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Steroids in Autoimmune Thyroid Disease
NCT04542278Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Nov 2020
- Primary completion
- Oct 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prednisone in Graves' disease and Hashimoto's thyroiditis (2 arms), sponsored by University of Wisconsin–Madison. Primary endpoints: Thyroid Difficulty Scale Score at 4 weeks, Percent Change From Baseline Mean in Autoantibody Levels up to 6 months and 3 more. Started Nov 2020; status: completed.
02
Drugs
prednisone
03
Conditions
Graves' diseaseHashimoto's thyroiditis
Beyond the preview
Go deeper on NCT04542278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04542278.